Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street as weakness in nutrition and diagnostics ...

A few weeks ago, an allergist prescribed a two-week course of an oral steroid to clear up my sinus inflammation. Before I ...

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

Investors feel optimistic about Abbott's robust strength in the Core Diagnostics business. Yet, unfavorable forex impacts are concerning.

has seen a large boost to sales from strong demand for FreeStyle Libre - its continuous glucose monitor. Abbott had been facing supply issues for its Libre devices and said it will meet the demand ...

Abbott has received an innovation award for Lingo, its first consumer biowearable over-the-counter device designed to support ...

Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes ...

Abbott Laboratories is a well-diversified health care company, with four distinct units: medical devices, diagnostics, ...

In our view, Abbott's FreeStyle Libre blood glucose monitor franchise is one of the most compelling innovations the firm has ever launched. Further, the pandemic provided a boon to the diagnostics ...

Blood glucose measurement is a critical aspect of managing diabetes in veterinary medicine, particularly for dogs and cats. Accurate monitoring of blood glucose levels helps veterinarians and pet ...

Abbott Laboratories on Wednesday forecast annual profit in line with Wall Street estimates, as it expects elevated ...